Get the Stockscreener App
0.045
16.86%
-0.0206
Acutus Medical Inc stock is traded at $0.045, with a volume of 2,111.
It is down -16.86% in the last 24 hours and down -71.77% over the past month.
See More
Previous Close:
$0.0656
Open:
$0.0011
24h Volume:
2,111
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
$19.66M
Net Income/Loss:
$-32.79M
P/E Ratio:
-0.0363
EPS:
-1.24
Net Cash Flow:
$-60.99M
1W Performance:
-16.86%
1M Performance:
-71.77%
6M Performance:
-76.88%
1Y Performance:
-93.82%
1-Day Range:
$0.0011
$0.0022
1-Week Range:
$0.0011
$0.0022
52-Week Range:
$0.0011
$0.0022
Acutus Medical Inc Stock (AFIB) Company Profile
Compare AFIB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AFIB
Acutus Medical Inc
|
0.0022 | 0 | 19.66M | -32.79M | -60.99M | -1.24 |
|
ABT
Abbott Laboratories
|
132.95 | 232.62B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.58 | 153.61B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.58 | 150.00B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.56 | 112.33B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.04 | 44.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Acutus Medical Inc Stock (AFIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-22-21 | Initiated | Goldman | Neutral |
| Jul-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-19-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-19-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-31-20 | Initiated | BTIG Research | Buy |
| Aug-31-20 | Initiated | BofA Securities | Buy |
| Aug-31-20 | Initiated | Canaccord Genuity | Hold |
| Aug-31-20 | Initiated | JP Morgan | Overweight |
| Aug-31-20 | Initiated | William Blair | Outperform |
View All
Acutus Medical Inc Stock (AFIB) Latest News
Head to Head Comparison: NAYA Biosciences (NASDAQ:NAYA) and Acutus Medical (NASDAQ:AFIB) - Defense World
Signed a definitive agreement to acquire AcQMap High Resolution Imaging and Mapping platform assets of Acutus Medical, Inc.. - MarketScreener
EnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology Assets - PR Newswire
Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Actions Deadlines - ACCESS Newswire
ASTR, HOL; AFIB; & BFLY Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors of Lead Plaintiff Deadlines - ACCESS Newswire
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors of Upcoming Deadlines - ACCESS Newswire
ASTR, HOL; AFIB; & BFLY Investor Reminder: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Looming Class Actions Deadlines - ACCESS Newswire
LAWSUITS FILED AGAINST BMBL, CLVT and AFIBJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST AFIB, CRNC and CELHJakubowitz Law Pursues Shareholder Claims - ACCESS Newswire
LAWSUITS FILED AGAINST AFIB, RIVN and AIJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
LAWSUITS FILED AGAINST AFIB, LCID and IBMJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Full list of companies laying off employees in April - Newsweek
Head-To-Head Survey: Acutus Medical (NASDAQ:AFIB) versus InfuSystem (NYSE:INFU) - The AM Reporter
Acutus Medical Reports Strong Revenue Growth in 2024 - TipRanks
Acutus Medical earnings beat by $0.36, revenue fell short of estimates - Investing.com Canada
Acutus Medical reports operating loss of USD 0.1 million in FY 24 - Medical Buyer
Acutus Medical Reports Full Year 2024 Financial Results - The Manila Times
Acutus Medical Reports Full Year 2024 Financial Results -March 24, 2025 at 04:02 pm EDT - Marketscreener.com
Acutus Medical Inc. (AFIB) reports earnings - Quartz
Acutus Medical (NASDAQ:AFIB) and InfuSystem (NYSE:INFU) Head to Head Comparison - Defense World
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com
Electrophysiology Market Trends & Growth | Industry Size, Share - openPR.com
Acutus Medical Inc to Host Earnings Call - ACCESS Newswire
Contrasting Acutus Medical (NASDAQ:AFIB) and Stevanato Group (NYSE:STVN) - Defense World
Acutus Medical strikes deal with Deerfield Funds, amends credit - Investing.com India
Electrophysiology Market: Opportunities, Challenges, - openPR
Layoffs in medtech: These companies recently reduced their workforce - MassDevice
Acutus Medical announces operational downsizing to solely support Medtronic distro deal - MassDevice
Acutus Medical Slashes 70% of Workforce in Major Restructuring, Pivots to Medtronic-Only Operations - StockTitan
Acutus Medical revenue jumps 156% to 5.3M in Q3 2024 - Medical Buyer
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results - The Manila Times
Medtronic Receives FDA Approval of Mapping and Ablation System and Catheter - Diagnostic and Interventional Cardiology
Acutus Medical finalizes settlement with Biotronik, ends agreements - Investing.com
Pulsed field ablation re-energizes the atrial fibrillation market - Clarivate
Pulsed Field Ablation Market Size | Industry Report, 2030 - Grand View Research
Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures - Diagnostic and Interventional Cardiology
AFIB Stock Price and Chart — OTC:AFIB - TradingView
Acutus Medical delisted from Nasdaq market due to non-compliance - MassDevice
Why Is Acutus Medical (AFIB) Stock Down 41% Today? - TradingView
Acutus Medical Full Year 2023 Earnings: US$0.41 loss per share (vs US$1.40 loss in FY 2022) - Simply Wall St
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Acutus laying off 65% of employees to focus solely on Medtronic heart device deal - MedTech Dive
Acutus torches ablation business to focus on manufacturing - BioWorld MedTech
Acutus Medical is laying off more than half of its workers - MassDevice
Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus Medical Inc., and Johnson and Johnson are some of the major companies in the marketTechnavio - PR Newswire
Acutus posts Q2 beats, expects AcQBlate ablation catheter approval by end of 2023 - MassDevice
Interview with the President and CEO: Tandem Diabetes Care Inc. (NASDAQ:TNDM) - The Wall Street Transcript
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation at the 2023 AF Symposium - Diagnostic and Interventional Cardiology
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic - Diagnostic and Interventional Cardiology
Acutus Medical Inc Stock (AFIB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.36%
Cap:
|
Volume (24h):